During the month of May, the Celiac Disease Foundation is taking the opportunity to honor the advocacy efforts of our dedicated, inspiring celiac disease patient community.
Continue ReadingDuring May, Celiac Disease Awareness Month, the Celiac Disease Foundation wants to take this opportunity to honor the advocacy efforts of our dedicated, inspiring celiac disease patient community.
Continue ReadingDDW 2023 showcased some of the latest research and innovations in celiac disease. These included promising early results from four investigational medications currently being tested for the treatment of celiac disease, as well as CDF research conducted in partnership with Takeda and Adelphi Real World.
Continue ReadingThe Celiac Disease Foundation is teaming up with celiac disease associations and societies around the world to celebrate this day with the Shine a Light on Celiac campaign.
Continue ReadingThe ILLUMINATE Studies are phase 2 clinical research studies evaluating an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingDigestive Disease Week, held this year in Chicago and virtually, is the world’s premier meeting for gastroenterology. The Celiac Disease Foundation is pleased to have presented original research – co-authored…
Continue ReadingMay is Celiac Disease Awareness Month! Raise or Donate between May 1 - May 31 and receive gluten-free product from Proud Sponsor King Arthur Baking Company to thank you for your support.
Continue ReadingMay Celiac Disease Awareness Month is just around the corner! Check out the ways you can get involved this May to help us accelerate treatments and a cure.
Continue ReadingThis week I will be traveling to attend an international symposium hosted by the Celiac Disease Center at Columbia University. This event is a valuable opportunity for leaders and influencers in celiac disease research to connect, share, and learn.
Continue ReadingThe Celiac Disease Foundation, a world leader in patient advocacy, and Takeda Development Center Americas, a global biopharmaceutical leader, today are proud to announce the Celiac Disease Foundation–Takeda Early Career Research Award.
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...